Novo Integrated Sciences Operating Expenses 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Novo Integrated Sciences Operating Expenses 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.6B
Quest Diagnostics (DGX)	$17.4B
DaVita (DVA)	$12.3B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.3B
Elanco Animal Health (ELAN)	$7.2B
RadNet (RDNT)	$5.3B
Option Care Health (OPCH)	$3.9B
Amedisys (AMED)	$3.2B
LifeStance Health (LFST)	$2.9B
Astrana Health (ASTH)	$2.9B
Addus HomeCare (ADUS)	$2.3B
U.S Physical Therapy (USPH)	$1.4B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Atai Life Sciences (ATAI)	$227M
Daxor (DXR)	$45M
MEDIROM Healthcare Technologies (MRM)	$14M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$13M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M